Recombinant Human OXLD1 protein (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human OXLD1 protein (His tag N-Terminus) is a Human Fragment protein, in the 46 to 147 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
C17orf90, OXLD1, Oxidoreductase-like domain-containing protein 1
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human OXLD1 protein (His tag N-Terminus) (AB181933)
15% SDS-PAGE analysis of 3 μg ab181933.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzymatic activity of OXLD1 influences cellular redox homeostasis impacting cellular metabolism and signaling. OXLD1 actively participates in a protein complex that modulates redox-sensitive transcription factors affecting gene expression linked to oxidative stress responses. This function highlights its role in maintaining cellular balance and adapting cellular activities in response to stress factors.
Pathways
The activities of OXLD1 integrate into the oxidative phosphorylation and glycolysis pathways influencing energy production and metabolism. In oxidative phosphorylation OXLD1 interacts with the NADH dehydrogenase complex which plays a significant part in the electron transport chain. Through these interactions OXLD1 establishes a regulatory connection with other proteins like NADH dehydrogenase contributing to ATP production and metabolic regulation.
Specifications
Form
Liquid
Additional notes
ab181933 was purified using conventional chromatography techniques.
General info
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com